No connection

Search Results

UHG

BEARISH
$1.17 Live
United Homes Group, Inc. · NASDAQ
$0.99 52W Range $4.78

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 22, 2026
Market cap
$68.83M
P/E
N/A
ROE
-26.2%
Profit margin
-4.0%
Debt/Equity
2.57
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
United Homes Group exhibits severe financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental improvement across all health metrics. The company is burdened by high leverage (Debt/Equity of 2.57) and negative shareholder returns (ROE of -26.16%), while revenue continues to contract. Despite a low Price-to-Sales ratio, the combination of negative profit margins and a critical disconnect between the current and quick ratios suggests significant liquidity risks. The long-term price performance is catastrophic, with a 91% decline over three years.

Key Strengths

Very low Price-to-Sales ratio (0.17)
Positive operating margin (1.16%)
Current ratio of 3.63 suggests short-term liquidity on paper
Price is trading relatively close to book value (P/B 1.20)
Positive earnings growth percentage (though likely from a very low base)

Key Risks

Extreme fundamental weakness (Piotroski 0/9)
High financial leverage with Debt/Equity at 2.57
Poor asset liquidity indicated by a Quick Ratio of 0.48
Negative net profit margins and negative ROE
Consistent revenue decline (-8.50% YoY)

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
11
Weak
Value
30
Future
20
Past
5
Health
0
Dividend
0
AI Verdict
High Risk / Distressed
Key drivers: Piotroski F-Score of 0/9, Severe multi-year price collapse, Negative ROE and Profit Margins, High Debt-to-Equity ratio
Confidence
90%
Value
30/100

P/S of 0.17 is superficially cheap, but Graham Number is unavailable due to negative earnings.

Positives
  • Low P/S ratio
  • P/B near 1.0
Watchpoints
  • No P/E due to lack of earnings
  • Value trap characteristics
Future
20/100

Revenue growth is -8.50% YoY, contradicting any bullish growth thesis.

Positives
  • High percentage growth in earnings (recovery from deep loss)
Watchpoints
  • Negative revenue growth
  • Declining quarterly revenue
Past
5/100

Consistent and severe destruction of shareholder value over 5 years.

Positives
No standout positives identified.
Watchpoints
  • 5Y Change: -88%
  • 3Y Change: -91%
  • 1Y Change: -47.8%
Health
0/100

The 0/9 Piotroski score is a definitive signal of financial instability.

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score 0/9
  • Debt/Equity 2.57
  • Quick Ratio 0.48
Dividend
0/100

Company is not in a position to return capital to shareholders.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • 0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$1.17

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for UHG and closest competitors.

Updated 2026-04-21
UHG
United Homes Group, Inc.
Primary
5Y
-88.0%
3Y
-91.0%
1Y
-47.8%
6M
-32.8%
1M
0.0%
1W
-0.8%
PRP
Purple Innovation, Inc.
Peer
5Y
-98.2%
3Y
-78.0%
1Y
+11.7%
6M
-25.3%
1M
-8.3%
1W
+3.0%
KND
Kandi Technologies Group, Inc.
Peer
5Y
-86.3%
3Y
-70.3%
1Y
-34.1%
6M
-34.1%
1M
-12.9%
1W
-2.4%
RGS
Regis Corporation
Peer
5Y
-89.3%
3Y
+25.1%
1Y
+59.0%
6M
-10.8%
1M
+12.4%
1W
+8.0%
THC
TH International Limited
Peer
5Y
-95.7%
3Y
-90.2%
1Y
-20.8%
6M
-15.7%
1M
+4.0%
1W
-2.8%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
1.2
P/S Ratio
0.17
EV/Revenue
0.47
EV/EBITDA
197.52
Market Cap
$68.83M

Profitability

Profit margins and return metrics

Profit Margin -4.0%
Operating Margin 1.16%
Gross Margin 17.66%
ROE -26.16%
ROA -0.01%

Growth

Revenue and earnings growth rates

Revenue Growth -8.5%
Earnings Growth +278.1%
Q/Q Revenue Growth -8.47%
Q/Q Earnings Growth +380.4%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
2.57
High debt
Current Ratio
3.63
Strong
Quick Ratio
0.48
Poor
Cash/Share
$0.41

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.1B
Gross Margin
17.5%
Op. Margin
1.3%
Net Margin
2.6%
Total Assets
$0.3B
Liabilities
$0.2B
Equity
$0.1B
Debt/Equity
3.82x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
44%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-11
$N/A

Consumer Cyclical Sector Comparison

Comparing UHG against 295 companies in the Consumer Cyclical sector (17 bullish, 97 neutral, 181 bearish)
Return on Equity (ROE)
-26.16%
This Stock
vs
-35.97%
Sector Avg
-27.3% (Below Avg)
Profit Margin
-4.0%
This Stock
vs
-5.65%
Sector Avg
-29.2% (Weaker)
Debt to Equity
2.57
This Stock
vs
1.37
Sector Avg
+88.4% (Higher)
Revenue Growth
-8.5%
This Stock
vs
14.32%
Sector Avg
-159.3% (Slower)
Current Ratio
3.63
This Stock
vs
2.45
Sector Avg
+48.2% (Stronger)

Similar Companies

Peer comparison within the same industry

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-03

UnitedHealth Group filed an 8-K on April 3, 2026, likely to announce its first-quarter financial results.

10-K
10-K
2026-03-13

UnitedHealth Group filed its 10-K on March 13, 2026, including sections on business operations, risk factors, and management's discussion and analysis. Specific financial highlights and risk details were not provided in the available excerpts.

8-K
8-K
2026-03-12
8-K
FORM 8-K
2026-02-23

UnitedHealth Group filed an 8-K on February 23, 2026, likely to announce its fourth-quarter and full-year financial results.

8-K
8-K
2026-01-16

UnitedHealth Group filed a Form 8-K on January 16, 2026, likely to report material corporate developments or preliminary year-end financial information.

10-Q
10-Q
2025-11-07

UnitedHealth Group filed its quarterly 10-Q report on November 7, 2025. The filing includes a section on Risk Factors under Item 1A, although specific financial highlights and risk details were not provided in the available excerpt.

8-K
8-K
2025-11-07
8-K
8-K
2025-11-06
8-K
FORM 8-K
2025-10-20

UnitedHealth Group filed an 8-K on October 20, 2025, likely to announce its third-quarter financial results.

8-K
8-K
2025-10-07
8-K
8-K
2025-10-01
10-Q
10-Q
2025-08-08
8-K
8-K
2025-08-07
8-K
8-K
2025-07-08
8-K
8-K
2025-06-13
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning UHG from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile